tirzepatide discontinued being FDA has announced that the shortage of #tirzepatide, the ingredient in Lilly's Mounjaro and Zepbound, has been resolved. Compounding #pharmacies are required to cease We have temporarily discontinued offering

Retatrutide side effects from TRIUMPH-4 Phase 3 trial data, including the novel dysesthesia signal Common Side Effects (from TRIUMPH-4 Phase 3) Source: Eli Lilly press release and medical information portal (medical.lilly.com), December 11, 2025

It is also popular in cleansing products as it helps to thicken them up and has some refatting and skin-smoothing effect

Why It Matters Ozempic is a prescription drug developed to manage blood sugar levels in patients with Type 2 diabetes

However, when used in combination with an ACE inhibitor or ARB, this effect is usually minimal and outweighed by the cardiovascular benefits

Dizziness, fainting, or sudden weakness These can be signs of blood pressure changes or an adverse reaction to the infusion

The key is management, not avoidance of health-saving medication